Pelecopan (BCX9930) is a potent, selective, orally active inhibitor of complement factor D with an IC 50 value of 14.3 nM. Pelecopan can target factor D to prevent both intravascular and extravascular hemolysis in PNH. Pelecopan also be used for other alternative pathway (AP) mediated diseases
In Vitro
Pelecopan has a potent, highly specific inhibitory activity for purified human factor D with an IC 50 value of 14.3 nM and also inhibits its proteolytic activity against factor B bound to C3b with an IC 50 of 28.1 nM. Pelecopan completely blocks hemolysis of PNH cells in vitro (with an IC 50 value of 29.5 nM in rabbit erythrocytes) and suppresses the accumulation of C3 fragments on PNH erythrocytes. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC50: 14.3 nM (complement factor D)
规格
别名
佩莱科潘
规格或纯度
≥97%
英文名称
Pelecopan
生化机理
Pelecopan(BCX9930)是一种强效、选择性、口服活性的补体因子D抑制剂,IC50值为14.3 nM。Pelecopan 可靶向 D 因子,防止 PNH 患者的血管内和血管外溶血。Pelecopan 还可用于其他领域。